New Canadian Study Brings Psychedelics into Everyday Wellness from Home.

It was great to hear from so many of you last week. I'm glad the newsletter on "resistance" hit home.

I wanted to share something this week that feels like a real shift, and it's happening right here in Canada. Health Canada just approved the first-ever clinical trial for at-home psilocybin microdosing to treat generalized anxiety. (Here's the news article, and the clinical trial info).

This is a big deal.

For a long time, the psychedelic conversation has focused on big-T trauma and severe, end-of-life conditions. This new trial focuses on the common, everyday struggles that keep good people from feeling great.

So many of us live with a low-grade hum of anxiety. It's not a five-alarm fire, just a persistent static in the background that drains energy and clouds focus. We get so used to it, we just accept it as the cost of a busy life.

But this research isn't just about "treating anxiety." It's about what happens when you finally turn down that static.

That background noise of anxiety is incredibly effective at masking a deeper signal—that quiet pull for more meaning, a better connection, or a new direction. It's hard to think about your purpose when your brain's bandwidth is just spent managing stress.

If you are curious about your own "static" level, here's a quick, confidential screening tool. It's not a diagnosis, just a way to get a clearer picture of where you're at.

So, the question for this week is: What's the static in your life? And what could you finally hear if you had the space to turn it down?

If you're ready to start addressing this, let's talk. A 1:1 session is the most practical next step. Book here.

Take care,

— Dr. John Álvarez

🔹Bio

🔹Reviews

🔹Newsletter Sign-Up